Having high insulin levels may be more than tough to manage when you have diabetes: New research shows it also appears to raise the risk of pancreatic cancer. In the study, scientists found excessive insulin levels overstimulated pancreatic acinar cells, which produce digestive juices. This overstimulation triggers inflammation that turns these cells into precancerous cells.… read on > read on >
FRIDAY, Nov. 10, 2023 (HealthDay News) – If you’re getting a tooth pulled or having another painful dental procedure, you’re much less likely to get opioids than you were just a few years ago, new research reveals. That’s good news because opioid abuse is a major issue in the United States and these drugs aren’t… read on > read on >
THURSDAY, Nov. 9, 2023 (HealthDay News) – Researchers are testing a toothpaste that aims to let patients who are sensitive to peanuts and other foods simply brush their allergies away. Doctors already treat some food allergy patients with oral immunotherapy — feeding them tiny, portioned and gradually increasing bits of their allergen under supervision for… read on > read on >
THURSDAY, Nov. 9, 2023 (HealthDay) — There’s good news for people with diabetes who are turning to drugs like Ozempic and Wegovy to treat their disease and lose weight: The drugs probably will not harm their vision. Semaglutide (the generic name for both medicines) can trigger rapid drops in blood sugar. Prior research had linked… read on > read on >
A second injectable diabetes drug has been approved for weight loss in overweight and obese adults, the U.S. Food and Drug Administration announced Wednesday. The weight-loss drug Zepbound contains the same active ingredient, tirzepatide, as the diabetes drug Mounjaro. Both medications are made by Eli Lilly and Co. “Obesity and overweight are serious conditions that… read on > read on >
WEDNESDAY, Nov. 8, 2023 (Healthday News) — A new drug to treat postpartum depression will cost nearly $16,000 for a 14-day course of treatment, a price tag that has doctors worried that some patients won’t be able to afford the medication. Zurzuvae (zuranolone) was first approved by the U.S. Food and Drug Administration back in August,… read on > read on >
WEDNESDAY, Nov. 8, 2023 (Healthday News) — The U.S. Food and Drug Administration said Tuesday that it plans to pull a veterinary drug used commonly in the pork industry because it might pose a cancer risk to humans who eat pig products. The antimicrobial, carbadox (Mecadox), is typically added to pig feed to fight infections… read on > read on >
The U.S. Food and Drug Administration has received at least three reports of people being hospitalized after taking counterfeit versions of the wildly popular weight-loss drugs known as semaglutides. At least one of these reports includes mention of a counterfeit version of the Novo Nordisk medication Ozempic, CBS News reported. Ozempic and Wegovy, another semaglutide… read on > read on >
When doctors advise patients to lose weight, an optimistic approach is more likely to get results. Researchers found that patients were more likely to participate in the recommended program and shed pounds if doctors presented obesity treatments as an “opportunity.” They compared that upbeat approach to emphasizing the negative consequences of obesity or using neutral… read on > read on >
Amid reports of more illnesses and additional product recalls, U.S. health officials have expanded their investigation into potentially lead-tainted pouches of apple cinnamon pureed fruit. The U.S. Food and Drug Administration said in an updated alert posted Friday that it has received reports of seven illnesses in at least five states possibly linked to contaminated… read on > read on >
